Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications
Authors
Keywords
-
Journal
Nature Communications
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-02-17
DOI
10.1038/s41467-022-28639-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression
- (2021) Francisco Javier Gil-Etayo et al. Frontiers in Cellular and Infection Microbiology
- A neutrophil activation signature predicts critical illness and mortality in COVID-19
- (2021) Matthew L. Meizlish et al. Blood Advances
- Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection
- (2021) Lina Ma et al. Science Immunology
- Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19
- (2021) Giuseppe Gritti et al. LEUKEMIA
- PD-L1 Dysregulation in COVID-19 Patients
- (2021) Francesco Sabbatino et al. Frontiers in Immunology
- Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative
- (2021) Tellen D. Bennett et al. JAMA Network Open
- Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- (2021) Obbina Abani et al. LANCET
- Tumor-derived soluble CD155 inhibits DNAM-1–mediated antitumor activity of natural killer cells
- (2020) Genki Okumura et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Proteomic and Metabolomic Characterization of COVID-19 Patient Sera
- (2020) Bo Shen et al. CELL
- Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
- (2020) Evangelos J. Giamarellos-Bourboulis et al. Cell Host & Microbe
- Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells
- (2020) Deanna M. Santer et al. PLoS Pathogens
- SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
- (2020) Víctor J. Costela-Ruiz et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent
- (2020) Alessio Mazzoni et al. JOURNAL OF CLINICAL INVESTIGATION
- Serum protein profiling reveals a landscape of inflammation and immune signaling in early-stage COVID-19 infection
- (2020) Xin Hou et al. MOLECULAR & CELLULAR PROTEOMICS
- Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection
- (2020) Vijendra Ramlall et al. NATURE MEDICINE
- Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
- (2020) Sara De Biasi et al. Nature Communications
- Drug treatments for covid-19: living systematic review and network meta-analysis
- (2020) Reed AC Siemieniuk et al. BMJ-British Medical Journal
- Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection
- (2020) Christoph B. Messner et al. Cell Systems
- Comprehensive mapping of immune perturbations associated with severe COVID-19
- (2020) Leticia Kuri-Cervantes et al. Science Immunology
- The first consecutive 5000 patients with Coronavirus Disease 2019 from Qatar; a nation-wide cohort study
- (2020) Ali S. Omrani et al. BMC INFECTIOUS DISEASES
- Covid-19: Anti-TNF drug adalimumab to be trialled for patients in the community
- (2020) Elisabeth Mahase BMJ-British Medical Journal
- Elevated Exhaustion Levels of NK and CD8+ T Cells as Indicators for Progression and Prognosis of COVID-19 Disease
- (2020) Mingyue Li et al. Frontiers in Immunology
- Integration of the Drug–Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts
- (2020) Sharon L Freshour et al. NUCLEIC ACIDS RESEARCH
- A Potential Role of Interleukin 10 in COVID-19 Pathogenesis
- (2020) Ligong Lu et al. TRENDS IN IMMUNOLOGY
- Serum nectin-2 and nectin-4 are diagnostic in lung cancer: which is superior?
- (2019) Kayhan Erturk et al. WIENER KLINISCHE WOCHENSCHRIFT
- Insights into IL‐29: Emerging role in inflammatory autoimmune diseases
- (2019) Jia‐Min Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Conflicting vascular and metabolic impact of the IL-33/sST2 axis
- (2018) Raffaele Altara et al. CARDIOVASCULAR RESEARCH
- Variable selection and validation in multivariate modelling
- (2018) Lin Shi et al. BIOINFORMATICS
- Interaction of PVR/PVRL2 with TIGIT/DNAM-1 as a novel immune checkpoint axis and therapeutic target in cancer
- (2018) Hauke Stamm et al. MAMMALIAN GENOME
- STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
- (2018) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- The role of IL-29 in immunity and cancer
- (2016) Noah E. Kelm et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Circulating blood and platelets supply glycosyltransferases that enable extrinsic extracellular glycosylation
- (2016) Melissa M Lee-Sundlov et al. GLYCOBIOLOGY
- Structural and Functional Attributes of the Interleukin-36 Receptor
- (2016) Guanghui Yi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma
- (2015) M. Karabulut et al. Clinical & Translational Oncology
- Interferon-λ: Immune Functions at Barrier Surfaces and Beyond
- (2015) Helen M. Lazear et al. IMMUNITY
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- Feature Selection with theBorutaPackage
- (2015) Miron B. Kursa et al. Journal of Statistical Software
- Relationship between interleukin-1 type 1 and 2 receptor gene polymorphisms and the expression level of membrane-bound receptors
- (2014) FF Vasilyev et al. Cellular & Molecular Immunology
- NKG2D signaling in cancer immunosurveillance
- (2014) Alejandro López-Soto et al. INTERNATIONAL JOURNAL OF CANCER
- Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability
- (2014) Erika Assarsson et al. PLoS One
- Soluble T cell immunoglobulin and mucin domain (TIM)-1 and -4 generated by A Disintegrin And Metalloprotease (ADAM)-10 and -17 bind to phosphatidylserine
- (2013) Olga Schweigert et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Directed Evolution of a Soluble Human IL-17A Receptor for the Inhibition of Psoriasis Plaque Formation in a Mouse Model
- (2013) Marianna Zaretsky et al. CHEMISTRY & BIOLOGY
- Identification of a soluble isoform of human IL-17RA generated by alternative splicing
- (2013) Miwa Sohda et al. CYTOKINE
- IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6
- (2012) Stefan Rose-John International Journal of Biological Sciences
- Soluble interleukin-18 receptor complex is a novel biomarker in rheumatoid arthritis
- (2011) Satoko Takei et al. ARTHRITIS RESEARCH & THERAPY
- Loss of CD4 + T Cell IL-6R Expression during Inflammation Underlines a Role for IL-6 Trans Signaling in the Local Maintenance of Th17 Cells
- (2010) Gareth W. Jones et al. JOURNAL OF IMMUNOLOGY
- Alternative mRNA splicing creates transcripts encoding soluble proteins from mostLILRgenes
- (2009) Des C. Jones et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Immunoglobulin-Like Transcript 3-Fc Suppresses T-Cell Responses to Allogeneic Human Islet Transplants in hu-NOD/SCID Mice
- (2008) G. Vlad et al. DIABETES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now